- Home
- ROIV vs CBSH Comparison
ROIV vs CBSH Comparison
Compare ROIV & CBSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CBSH
- Stock Information
- Founded
- ROIV 2014
- CBSH 1865
- Country
- ROIV United Kingdom
- CBSH United States
- Employees
- ROIV N/A
- CBSH N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CBSH Major Banks
- Sector
- ROIV Health Care
- CBSH Finance
- Exchange
- ROIV Nasdaq
- CBSH Nasdaq
- Market Cap
- ROIV 7.8B
- CBSH 9.0B
- IPO Year
- ROIV N/A
- CBSH N/A
- Fundamental
- Price
- ROIV $10.74
- CBSH $64.93
- Analyst Decision
- ROIV Buy
- CBSH Hold
- Analyst Count
- ROIV 4
- CBSH 7
- Target Price
- ROIV $17.50
- CBSH $64.86
- AVG Volume (30 Days)
- ROIV 7.0M
- CBSH 699.4K
- Earning Date
- ROIV 08-07-2025
- CBSH 07-16-2025
- Dividend Yield
- ROIV N/A
- CBSH 1.70%
- EPS Growth
- ROIV N/A
- CBSH 17.79
- EPS
- ROIV N/A
- CBSH 4.03
- Revenue
- ROIV $29,053,000.00
- CBSH $1,643,891,000.00
- Revenue This Year
- ROIV $2.64
- CBSH $8.42
- Revenue Next Year
- ROIV $378.09
- CBSH $9.11
- P/E Ratio
- ROIV N/A
- CBSH $16.09
- Revenue Growth
- ROIV N/A
- CBSH 4.97
- 52 Week Low
- ROIV $8.73
- CBSH $52.27
- 52 Week High
- ROIV $13.06
- CBSH $72.75
- Technical
- Relative Strength Index (RSI)
- ROIV 39.45
- CBSH 65.99
- Support Level
- ROIV $10.83
- CBSH $61.33
- Resistance Level
- ROIV $11.82
- CBSH $65.32
- Average True Range (ATR)
- ROIV 0.32
- CBSH 1.09
- MACD
- ROIV -0.09
- CBSH 0.42
- Stochastic Oscillator
- ROIV 1.83
- CBSH 92.87
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CBSH Commerce Bancshares Inc.
Commerce Bancshares Inc. is a $22 billion regional bank that provides a diversified line of financial services, including business and personal banking, wealth management, financial planning, and investments through its affiliated companies. Commerce Bank operates in more than 200 locations in the central United States. Commerce Bancshares also has operating subsidiaries involved in mortgage banking, leasing, credit-related insurance, venture capital, and real estate activities.